Back to article: Improving glucose and lipids metabolism: drug development based on bile acid related targets

FIGURE 2: Semisynthetic bile acid derivatives as FXR agonists and synthetic FXR nonsteroidal.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. Please refer to our "privacy statement" and our "terms of use" for further information.